Meningitis B Drug Developed
As per a research, which has been published in the Lancet Infectious Diseases medical journal, it has been revealed that Australian researchers have developed a kind of vaccine, which is able to prevent meningitis B.
Lead author Peter Richmond, from the University of Western Australia's School of Pediatrics and Child Health, said that in order to reach at the above given result, they enrolled more than 500 adolescents from Australia, Poland and Spain.
The test group was given the vaccine and the antibodies developed by them were able to protect 90% of strains in the meningitis B group. The disease is quite common in countries like the United States, Europe and Australia.
Peter said that the disease generally affects adolescents in which they develop an inflammation of the lining around the brain. In severe cases, the disease also affects spinal cord also and its fatality rate is between
5 and 14%.
Richmond said that the research has not finished yet. They are going to conduct a further research in which they are going to target another 200 children, who are extremely sensitive to the disease. If the drug shows effect even on the second time then they would get license for the drug. It will take about three to five years to reach at that level, said Richmond.
Life is becoming busier than ever and the food...Read More
A truck driver, who is on trial for an accident...Read More
A container ship sailing around 500km north of New...Read More
When tragedies like Orlando shooting incident...Read More
Shares of Baidu dropped five percent during the...Read More
On Tuesday, Crude oil futures dropped during early...Read More